Sign up
Pharma Capital

Namaste Technologies completes acquisition of 49% of established cannabis delivery group Pineapple Express

The latter offers same-day, 60-minute delivery services in multiple industries across Canada
Signing a deal
The firm has now completed the acquisition of 49% of Toronto-based Pineapple Express Delivery Inc

Namaste Technologies Inc (CVE:N) (OTCMKTS:NXTTF) has completed its previously announced acquisition of 49% of Pineapple Express Delivery Inc.

The latter offers same-day, 60-minute delivery services in multiple industries across Canada, and has established security and delivery protocols for the delivery of medical and recreational cannabis across the country.

READ THE BIG PICTURE: Namaste Technologies looks to become the ‘Amazon of cannabis’ with its integrated, intelligent cannabis experienc e

"Pineapple Express is a premier delivery company when it comes to cannabis in Canada, and we look forward to working closely with Randy and his team to continue to grow the business," said Meni Morim, interim CEO at Namaste.

"Having Pineapple Express as part of our family is an efficient way to get medicinal cannabis to customers in the Greater Toronto Area and across Canada as quickly and efficiently as possible. We remain focused on execution of our 2019 strategy and are pleased to have seen this project through," he added.

Last summer, Namaste unveiled a subscription agreement to acquire 15% of Toronto-based Pineapple for $1 million, consisting of $850,000 in cash and $150,000 in Namaste shares.

In December, it said it had struck a purchase agreement with Pineapple Express shareholders to acquire a further 34%, and issued them with shares worth around $3.06 million, based on the closing price of Namaste shares on the TSX Venture Exchange on December 14 last year.

Right to buy more

Namaste has the right to buy a further 10% of Pineapple Express shares for $1.2 million within 14 months from the closing of the subscription agreement.

In connection with the deal, Darren Gill, chief strategy officer of Namaste will be appointed a director of Pineapple Express.

Contact Giles at [email protected]

Follow him on Twitter@Gile74

Giles_55af4ddca6481.jpg
Why Invest In Namaste Technologies Inc? Read More Here

Register here to be notified of future N Company articles
View full N profile View Profile
View All

Related Articles

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.